Resource utilization and costs of age-related macular degeneration
- PMID: 17290647
- PMCID: PMC4194952
Resource utilization and costs of age-related macular degeneration
Abstract
Data were analyzed from the 1999-2001 Medicare Beneficiary Encrypted Files for patients with age-related macular degeneration (AMD), an ophthalmic condition characterized by central vision loss. Classifying AMD subtype by International Classification of Diseases, Ninth Revision, Clinical Modifications (ICD-9-CM) (Centers for Disease Control and Prevention, 2003) code, resource utilization rates increased with disease progression. Individuals with more severe disease (wet only or wet and dry AMD) had greater costs than did those with less severe disease (drusen only or dry only). Costs among patients with wet disease increased yearly at rates exceeding inflation, possibly due in part to increased rates of treatment with photodynamic therapy among these individuals and the aging of the population.
References
-
- American Academy of Ophthalmology. San Francisco, California: Guideline—Age-Related Macular Degeneration. Internet address: http://www.guideline.gov/summary/summary.aspx?view_id=1&doc_id=4349 (Accessed 2005.)
-
- Centers for Disease Control and Prevention. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Internet address: http://www.cdc.gov/nchs/about/other-act/icd9/abticd9.htm (Accessed 2005.)
-
- Centers for Disease Control and Prevention. Prevalence of Visual Impairment and Selected Eye Diseases Among Persons Aged >/=50 Years With and Without Diabetes—United States, 2002. MMWR Morbidity and Mortality Weekly Report. 2004 Nov 19;53(45):1069–1071. - PubMed
-
- Centers for Medicare & Medicaid Services. Healthcare Common Procedure Coding System (HCPCS) Internet address: http://www.cms.hhs.gov/medicare/hcpcs/default.asp (Accessed 2005.)
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical